Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गयासीडीसी ने 31 दिसंबर तक लेवल 3 की चेतावनी जारी कर दी है?
सीडीसी ने 31 दिसंबर तक लेवल 3 की चेतावनी जारी कर दी है?
हाँ
$112,110 वॉल्यूम
$112,110 वॉल्यूम
31 दिस, 2026
हाँ
$112,110 वॉल्यूम
$112,110 वॉल्यूम
31 दिस, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
बाज़ार खुला: Jan 19, 2026, 3:15 PM ET
वॉल्यूम
$112,110समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
वॉल्यूम
$112,110समाप्ति तिथि
31 दिस, 2026बाज़ार खुला
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus prices a 75% implied probability for the CDC issuing a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips to high-risk destinations—by December 31, 2026, driven by a cluster of new Level 2 notices in March for meningococcal disease in the Democratic Republic of the Congo, yellow fever in Venezuela, chikungunya in Mayotte, and global poliovirus circulation across 30+ countries. These reflect heightened outbreak activity, compounded by a U.S. measles epidemic surpassing 1,714 confirmed cases as of April 9 per CDC data, amid declining vaccination rates and international spread risks. Persistent H5N1 avian influenza outbreaks in U.S. dairy cattle and wild birds, though with no new human infections reported last week, underscore spillover potential. Weekly CDC FluView updates and WHO surveillance reports remain key catalysts for potential escalation.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया
बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न